Colby Pharmaceutical Company - Board of Directors

Loading menu...

Site Map | Sign Up | Unsubscribe

Prostate cancer is the second leading cause of cancer deaths among US men

Over 200,000 new patients are diagnosed with prostate cancer every year in the US alone

About 35,000 of these men have advanced metatstatic prostate tumor for whom there is no cure

Prostate Cancer

Colby Mission

Drug Pipeline

About Colby

Mission
Company Overview
Management Team
Corporate History
Board of Directors
Kenneth W. Narducy, PhD, MBA
Craig Heim, MBA
Anne K Vallerga, PhD
David A Zarling, PhD, MBA
Scientific Advisory Board
Selected Publications
Investments

Board of Directors

The Company's Board of Directors is made up of academic and industry leaders and innovators. They have dedicated their insight, passion and expertise to guide Colby Pharmaceutical Company.